Bone and Joint Infection Clinical Trial
Official title:
Lyon BJI Cohort Study
The prospective Cohort includes all patients with bone or joint infection (BJI), with or
without implant. The aim of this Cohort is to improve the knowledges about the treatment
failure and the occurrence of serious adverse events. Various data of patients included are
collected and will be analysed.
Patients with a bone or joint infection are treated at the department of infectious
diseases, at Infectious disease department of Hospices Civils de Lyon. They have regularly a
consultation with a physician: 2-3 weeks after surgery, 6 weeks after surgery, 3 months
after surgery, 6 months after surgery, 12 months after surgery and 24 months after surgery.
It allows to the physician to follow the evolution of the patient under treatment and after
discontinuation of the treatment.
Several data are collected during the follow-up concerning: demographics data, treatment
including the use of off-label antibiotics for the treatment of BJI, adverse events,
microbiology, surgeries, healing or relapse, date of symptoms, ASA score, implant or not. If
there is an implant, the date of implantation and the number of the prosthesis infected are
collected.
This cohort allows to improve knowledge concerning the treatment failure and the occurrence
of adverse events.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05421312 -
Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip
|
Phase 4 | |
Active, not recruiting |
NCT04563325 -
Oral-only Antibiotics for Bone and Joint Infections in Children
|
Phase 4 | |
Completed |
NCT03627000 -
Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection
|
||
Completed |
NCT03311113 -
Adherence to Oral Antibiotics In Patients With Osteoarticular Infections
|
||
Recruiting |
NCT05753215 -
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
|
Phase 2 | |
Completed |
NCT03209921 -
Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections
|
N/A | |
Completed |
NCT04418882 -
Septic Management and Outcome of Open Fracture
|
||
Completed |
NCT05248490 -
Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
|
N/A | |
Completed |
NCT03624855 -
Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
|
||
Recruiting |
NCT04496024 -
Ofloxacin Concentration-toxicity Relationship in the Elderly
|
N/A | |
Recruiting |
NCT04933344 -
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
|
||
Recruiting |
NCT04538053 -
BonE and Joint Infections - Simplifying Treatment in Children Trial
|
Phase 4 | |
Completed |
NCT04373278 -
Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort Study
|
||
Completed |
NCT03209934 -
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
|
N/A | |
Recruiting |
NCT03611634 -
Consitution Of A Biological Collection From Samples From The Gut Microbiote In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine
|
||
Completed |
NCT03177369 -
Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration
|
N/A | |
Recruiting |
NCT04722926 -
Lyon PJI Retrospective Cohort Study
|
||
Completed |
NCT03852784 -
Osteoarticular Infections With Pneumococcal
|
||
Recruiting |
NCT03796104 -
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
|
||
Completed |
NCT03848104 -
Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
|